METTL3 Loss Unlocks Transposable Elements and Expands Mouse Stem Cell Potency

In a comprehensive investigation of RNA epigenetic regulation during early development, researchers have established that loss of methyltransferase-like 3 prompts mouse embryonic stem cells to reactivate silent transposable genetic elements and transition toward an expanded developmental state resembling two-cell embryos. The catalytic enzyme METTL3 serves as the primary writer responsible for depositing N6-methyladenosine marks onto mammalian messenger RNA molecules. Operating across varied stem cell culture platforms, the study demonstrates that removing METTL3 triggers broad transcriptomic shifts characterized by derepression of retrotransposons alongside hallmark totipotency-associated transcripts. Utilizing stable CRISPR genetic deletions alongside targeted chemical-genetic degradation systems, the team tracked how enzymatic deficiency alters transcriptional control and developmental potency in mouse blastocysts. These findings elucidate a direct regulatory role for epitranscriptomic modifications in restricting developmental plasticity and stabilizing cell fate in mammalian lineages.

Chemical modification of messenger RNA through N6-methyladenosine, commonly abbreviated as m6A, represents a widespread epigenetic mechanism shaping RNA metabolism, translational dynamics, and gene expression across eukaryotic organisms, including mammals and plants. Within the multi-subunit catalytic writer complex, the METTL3 protein provides the essential enzymatic core responsible for transferring methyl groups onto adenosine bases within cellular transcripts. Across diverse species, METTL3 maintains an evolutionary conserved architectural framework, distinguished by an invariant DPPW catalytic active site motif located in its sixth exon. Prior biochemical characterizations have verified that point mutations or sequence deletions targeting this conserved DPPW active center cause an almost complete loss of the enzyme’s capacity to catalyze m6A modification.

A substantial proportion of mammalian genetic architecture consists of mobile genetic elements, with transposable elements occupying roughly forty-five percent of both human and mouse genomic sequences. These repetitive regions comprise major structural classes, including long interspersed nuclear elements, short interspersed nuclear elements, and endogenous retroviral elements. Transcripts derived from transposable elements exhibit an exceptionally high enrichment of internal m6A chemical tags, which normally facilitate recruitment of reader factors such as the nuclear protein YTHDC1. In standard stem cell models, YTHDC1 binds m6A-modified retrotransposon transcripts and coordinates with histone methyltransferases, notably SETDB1, to deposit repressive histone H3 lysine 9 trimethylation marks that silence chromatin at transposable element loci. However, prior investigations produced contradictory observations regarding how METTL3 ablation affects mobile element expression, with separate laboratories reporting conflicting directions of regulation for LINE elements under divergent culture formulations.

To resolve these longstanding discrepancies and determine whether external culture conditions or cellular heterogeneity dictate retrotransposon behavior, researchers engineered a targeted knockout cell line utilizing mouse embryonic stem cells derived from inner cell masses of 129 strain embryos. Employing CRISPR-Cas9 gene editing, the team excised exons 4 through 7 within the endogenous Mettl3 locus, intentionally deleting the critical DPPW catalytic motif located within exon 6. This targeted excision caused a frameshift alteration that eliminated functional METTL3 expression, confirmed by immunoblotting demonstrating an absence of detectable METTL3 protein in whole-cell extracts. Mass spectrometry quantification of nucleosides in purified messenger RNA confirmed that the ratio of m6A to adenosine dropped to virtually undetectable levels in knockout cells. Furthermore, quantitative real-time PCR validated the complete disruption of Mettl3 transcript synthesis, confirming the establishment of a rigorously verified null cellular platform.

Because external environmental signals can alter stem cell behavior, investigators systematically compared wild-type and Mettl3-null embryonic stem cells across multiple widely used culture media formulations, specifically serum-supplemented medium with leukemia inhibitory factor, serum-free chemically defined N2B27 medium supplemented with two small-molecule inhibitors and leukemia inhibitory factor, and a dual-supplemented serum formulation containing both inhibitors. In the presence of serum without kinase inhibitors, METTL3-deficient stem cells exhibited distinctive phenotypic alterations, spreading into spindle-shaped monolayers characterized by large intercellular spaces and failing to form colonies. Conversely, when maintained in serum-free conditions containing inhibitors of glycogen synthase kinase 3 and mitogen-activated protein kinase kinase, knockout cells assembled flattened colony-like structures. Despite these morphological divergences, quantitative mass spectrometry confirmed that the depletion of messenger RNA m6A marks remained invariant across all culture regimens, proving that catalytic loss operated independently of culture chemistry.

Systematic transcriptional profiling through quantitative real-time PCR and high-throughput bulk RNA sequencing demonstrated that transposable elements were robustly derepressed in METTL3-deficient cells regardless of whether serum or chemically defined media were utilized. Transcripts originating from prominent retrotransposon classes, specifically long interspersed nuclear element 1 families and intracisternal A-particles, exhibited significant upregulation in knockout cells compared to wild-type controls. High-throughput sequence mapping to the mouse reference genome confirmed that elevated expression of repetitive elements occurred under serum-containing conditions, serum-free conditions, and dual-inhibitor serum formulations alike. Instead, the experimental evidence revealed that METTL3 loss uniformly relieves transcriptional suppression of mobile DNA elements across standard embryonic stem cell culture environments, establishing retrotransposon activation as an intrinsic consequence of epitranscriptomic impairment.

To confirm whether the observed upregulation of transposable elements stemmed directly from the catalytic methyltransferase function of METTL3 rather than non-catalytic structural roles, investigators conducted functional genetic rescue assays. The team constructed mammalian expression vectors harboring full-length wild-type METTL3, a catalytically defective point mutant in which the DPPW catalytic sequence was converted to APPA at amino acids 395 through 398, or a truncated variant spanning amino acids 242 through 448 that lacked the zinc finger domain and catalytic core. Overexpressing full-length wild-type METTL3 in knockout cells restored retrotransposon transcript levels back to baseline wild-type measurements. In striking contrast, introducing either the catalytically inactive APPA mutant or the truncated protein failed to restore retrotransposon repression. These controlled rescue experiments provided conclusive evidence that the restraint of mobile genetic elements in mouse embryonic stem cells depends strictly on the catalytic RNA methyltransferase activity of METTL3.

A critical mechanistic question was whether the accumulation of retrotransposon RNAs in METTL3-deficient cells resulted from enhanced transcriptional firing at genomic loci or from decelerated degradation of non-methylated RNA molecules. To distinguish between new transcript synthesis and altered decay kinetics, the authors executed 5,6-dichlorobenzimidazole 1-beta-D-ribofuranoside-chase and transient transcriptome sequencing, known as DRB-TT-seq. Embryonic stem cells were treated with the reversible RNA polymerase II inhibitor DRB for three hours to synchronize transcriptional cessation, followed by a wash step to reinitiate transcription during a pulse labeling period with 4-thiouridine for zero and eight minutes. Newly synthesized nascent transcripts were subsequently biotinylated, captured on streptavidin beads, and processed for high-throughput sequencing. The nascent sequencing profiles demonstrated a pronounced elevation of newly generated transcripts for representative retrotransposons, including IAPEz-int and L1Md_Gf, confirming that transposable element accumulation in METTL3-null cells is driven primarily by active de novo transcription.

Parallel transcriptomic investigations revealed that METTL3 depletion also led to a significant upregulation of the embryonic two-cell-like transcriptional program. During normal preimplantation development, cleavage-stage two-cell embryos express distinct totipotency-associated markers alongside specific retrotransposons such as murine endogenous retrovirus-L and MT2 elements. In Mettl3 knockout stem cells, gene set enrichment analyses and targeted reverse transcription quantitative PCR identified marked increases in the expression of classic two-cell genes, including members of the Zscan4 family, Dux, and Usp17l gene clusters. Similar to retrotransposon activation, the induction of this two-cell transcriptional profile persisted across both serum-containing and serum-free culture conditions. Furthermore, introducing full-length wild-type METTL3 completely extinguished the ectopic two-cell gene signature, whereas introducing the catalytic APPA mutant or truncated construct failed to repress these embryonic transcripts, establishing that two-cell program induction is also dependent on METTL3 catalytic activity.

Because constitutive genetic ablation of Mettl3 causes extensive differentiation defects and impairs long-term cell viability in chimeric embryos, the authors engineered a chemical-genetic degron platform to evaluate developmental potential without the confounding impacts of prolonged passage. Using homologous recombination, an FKBP12(F36V) tag was knocked into the endogenous Mettl3 locus immediately preceding the termination codon, generating a Mettl3-KI-HA-FKBP stem cell model. Administration of the small-molecule degrader dTAGV-1 at a concentration of five hundred nanomolar induced rapid and nearly complete proteasomal degradation of the METTL3 fusion protein within forty-eight hours, verified by immunoblotting. Quantitative mass spectrometry confirmed that this targeted chemical degradation eliminated m6A RNA modifications with comparable efficiency to permanent CRISPR knockouts. By combining this rapid degron system with stable constitutive mCherry fluorescent protein expression, researchers created an ideal platform to trace the immediate lineage contributions of METTL3-depleted cells during mammalian preimplantation development.

To rigorously test whether METTL3 degradation expanded the developmental potency of embryonic stem cells beyond the pluripotent state, the team performed aggregated blastocyst chimera assays. The researchers aggregated ten to fifteen mCherry-labeled Mettl3-KI-HA-FKBP stem cells, pretreated with either dTAGV-1 or dimethyl sulfoxide control, with zona-free eight-cell host embryos in concave microwells. Following twenty-four hours of culture to the E3.5 blastocyst stage, whole-mount immunofluorescence staining was conducted using antibodies against the trophectoderm lineage transcription factor CDX2 and nuclear DAPI. In striking contrast to control cells, METTL3-deficient stem cells were detected within the trophectoderm layer and exhibited distinct colocalization with CDX2 in over seventy percent of chimeric blastocysts, providing functional proof of expanded developmental potency.

The demonstration that METTL3 depletion enables embryonic stem cells to breach traditional lineage restrictions and integrate into extraembryonic trophectoderm tissues highlights the profound role of m6A epitranscriptomic modifications in cell fate determination. While transposable element activation frequently coincides with the induction of two-cell programs, the authors contextualized their findings within existing genetic evidence, noting that derepressing general retrotransposons like LINE1 or intracisternal A-particles is distinct from activating MERVL, which specifically drives two-cell stage conversion and embryo viability. Deposited under BioProject accession PRJCA040908, these findings establish that METTL3-mediated catalytic m6A deposition acts as an essential epigenetic lock that silences retrotransposons, restricts totipotent gene expression, and limits the developmental plasticity of mammalian pluripotent stem cells.

Subject of Research: METTL3-mediated m6A regulation of transposable elements and 2C-like developmental potency in mouse embryonic stem cells

Article Title: The role of METTL3 in transposable elements regulation and 2C-like program induction in mouse embryonic stem cell

Article References: Chen, X., Chen, B., Zhao, Y., Wen, Z., Hao, J., Jin, L., Li, D., Quan, X., Wu, K., Deng, M., Bao, X., Wang, J., & Chen, J. (2025). The role of METTL3 in transposable elements regulation and 2C-like program induction in mouse embryonic stem cell. Cell Regeneration, 14(1), Article 47. https://doi.org/10.1186/s13619-025-00262-w

Image Credits: AI Generated

DOI: 10.1186/s13619-025-00262-w

Keywords: METTL3, m6A methylation, mouse embryonic stem cells, transposable elements, 2C-like state, totipotency, CRISPR-Cas9, dTAG system, trophectoderm, LINE1, IAP, MERVL, Zscan4, chimera assay, CDX2, DRB-TT-seq, epitranscriptomics